Capital Impact Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,713
| Closed | -$503K | – | 64 |
|
|
2024
Q1 | $503K | Buy |
22,713
+6,159
| +37% | +$136K | 0.65% | 67 |
|
|
2023
Q4 | $357K | Hold |
16,554
| – | – | 0.47% | 81 |
|
|
2023
Q3 | $280K | Hold |
16,554
| – | – | 0.47% | 88 |
|
|
2023
Q2 | $227K | Buy |
16,554
+1,102
| +7% | +$15.1K | 0.25% | 152 |
|
|
2023
Q1 | $351K | Hold |
15,452
| – | – | 0.43% | 111 |
|
|
2022
Q4 | $364K | Buy |
15,452
+997
| +7% | +$23.5K | 0.36% | 123 |
|
|
2022
Q3 | $289K | Buy |
14,455
+485
| +3% | +$9.7K | 0.29% | 143 |
|
|
2022
Q2 | $307K | Sell |
13,970
-3,561
| -20% | -$78.3K | 0.28% | 153 |
|
|
2022
Q1 | $786K | Sell |
17,531
-6,898
| -28% | -$309K | 0.57% | 72 |
|
|
2021
Q4 | $1.05M | Buy |
24,429
+7,726
| +46% | +$331K | 0.72% | 53 |
|
|
2021
Q3 | $1.11M | Buy |
16,703
+3,500
| +27% | +$233K | 0.44% | 95 |
|
|
2021
Q2 | $968K | Buy |
13,203
+11,172
| +550% | +$819K | 0.31% | 111 |
|
|
2021
Q1 | $139K | Sell |
2,031
-22,969
| -92% | -$1.57M | 0.05% | 108 |
|
|
2020
Q4 | $1.68M | Buy |
+25,000
| New | +$1.68M | 0.41% | 91 |
|